XOOMAR

Elevance Health, Inc. (ELV)

Every FINRA and SEC series the site collects for Elevance Health, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as hospital & medical service plans.

Download CSV

5.4M

Short interest

settlement 2026-08-14

5.7

Days to cover

-3.2% vs prior

65.3%

Short share of volume

2026-09-11

1,635

Fails to deliver

settlement 2026-08-04

$1.0M

Insider flow, 90 days

2 buys, 0 sells

As of 2026-09-11.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 14 August 2026, short interest in ELV is 5,405,640 shares, down 619,674 shares over the last month. Over the last 48 readings it ranged from 1,776,654 shares (30 August 2024) to 6,604,471 shares (29 May 2026). At the reported average volume of 953K shares a day that is 5.7 days to cover, elevated.

Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/elv" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-08-145,405,640-3.2%952,8315.67
2026-07-315,586,082-7.3%1,422,0313.93
2026-07-156,025,314+0.3%1,709,5463.52
2026-06-306,009,556-4.3%1,835,6063.27
2026-06-156,281,369-4.9%1,785,1603.52
2026-05-296,604,471+8.3%1,520,1944.34
2026-05-156,101,072+18.3%1,658,6843.68
2026-04-305,158,417+16.8%2,032,9732.54
2026-04-154,417,945+11.3%1,490,8282.96
2026-03-313,970,576+8.2%1,622,0362.45
2026-03-133,669,028-13.2%3,161,0161.16
2026-02-274,227,962-9.1%1,581,8902.67
2026-02-134,649,830+29.3%1,722,4522.70
2026-01-303,595,465-2.5%2,295,1531.57
2026-01-153,685,633-10.1%1,224,9163.01
2025-12-314,098,765-14.0%1,393,9472.94
2025-12-154,764,383+22.7%1,706,2132.79
2025-11-283,883,536-3.9%1,489,4612.61
2025-11-144,041,947+16.2%1,537,7222.63
2025-10-313,479,088+27.4%1,907,0471.82
2025-10-152,731,969-14.7%1,815,7001.50
2025-09-303,202,284-12.9%1,920,5321.67
2025-09-153,677,507+36.2%2,104,1851.75
2025-08-292,700,482-14.5%2,069,8901.30

Daily short volume

FINRA Reg SHO, last 60 sessions. JSON

As of 11 September 2026, the short share of ELV volume is 65.3%, down 5.3 points over the last five sessions. Over the last 52 readings it ranged from 34.6% (14 August 2026) to 75.7% (4 September 2026). The latest reading is 5.9 points above the 30-session average of 59.4%, on 372K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-09-11243K372K65.3%3,017
2026-09-10465K826K56.3%4,226
2026-09-09334K455K73.4%0
2026-09-08291K465K62.5%67
2026-09-04228K301K75.7%353
2026-09-03295K417K70.7%4,603
2026-09-02168K295K57.0%2,632
2026-09-01213K323K66.0%750
2026-08-31129K204K63.2%102
2026-08-28114K178K63.7%0
2026-08-27123K240K51.2%39
2026-08-2689K208K42.9%75
2026-08-25143K242K59.3%21
2026-08-24175K263K66.7%801
2026-08-21106K170K62.5%1,189
2026-08-20124K207K60.1%756
2026-08-19251K411K61.1%163
2026-08-18207K313K66.2%90
2026-08-17301K414K72.7%790
2026-08-1469K200K34.6%685
2026-08-13110K233K47.3%187
2026-08-12129K266K48.6%2,209
2026-08-11157K308K51.1%2,436
2026-08-10148K224K66.0%110
2026-08-07126K269K46.9%0
2026-08-06201K300K67.0%38
2026-08-05277K491K56.3%113
2026-08-04219K464K47.2%213
2026-08-03276K472K58.5%207
2026-07-31212K348K60.9%1,147

Fails to deliver

SEC, by settlement date. JSON

As of 4 August 2026, the fails-to-deliver balance in ELV is 1,635 shares, down 3,696 shares over the last settlement date. Over the last 46 readings it ranged from 1 share (7 April 2026) to 116,053 shares (10 February 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-08-041,635$382.77$626K
2026-08-035,331$375.84$2.0M
2026-07-0223,410$416.19$9.7M
2026-06-304,812$388.03$1.9M
2026-06-256$384.00$2K
2026-06-2321,398$394.82$8.4M
2026-06-2225,439$388.50$9.9M
2026-06-166$401.89$2K
2026-06-101,099$424.43$466K
2026-04-153$313.35$940
2026-04-071$302.61$303
2026-04-06101$300.74$30K
2026-04-01127$292.75$37K
2026-03-31384$284.79$109K
2026-03-2612,713$296.09$3.8M
2026-03-2531$290.33$9K
2026-03-1924$294.95$7K
2026-03-10135$280.74$38K
2026-03-0967,056$289.64$19.4M
2026-03-0221$320.00$7K
2026-02-172,366$346.80$821K
2026-02-12633$330.25$209K
2026-02-10116,053$327.50$38.0M
2026-02-06156$332.25$52K
2026-02-0212$345.74$4K
2026-01-28480$322.92$155K
2026-01-202,856$374.87$1.1M
2026-01-1640$381.93$15K
2026-01-125$372.83$2K
2026-01-092$374.77$750

Insider trades

SEC Form 4, newest first, 50 of 65 shown. JSON

Insiders at ELV reported 2 open-market buys worth $1.0M in the last 90 days and no open-market sells. Clustered voluntary buying is historically the stronger insider signal because insiders buy for one reason. Latest filing: Wessling Erin M (EVP &amp; Chief Legal Officer) on 2026-09-03.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-09-03Wessling Erin MEVP &amp; Chief Legal OfficerTax withholding255$414.78$106K7K
2026-09-02Wessling Erin MEVP &amp; Chief Legal OfficerTax withholding94$405.84$38K7K
2026-09-02Craig Ryan REVP &amp; Chief HR OfficerTax withholding144$405.84$58K7K
2026-07-17BOUDREAUX GAILPresident and CEOBuy2K$368.25$753K172K
2026-07-17BOUDREAUX GAILPresident and CEOBuy680$366.41$249K170K
2026-05-19Penczek Ronald WCAO &amp; ControllerSell2K$403.13$617K4K
2026-05-19Penczek Ronald WCAO &amp; ControllerOption exercise877$311.48$273K6K
2026-05-19Penczek Ronald WCAO &amp; ControllerOption exercise654$271.27$177K5K
2026-05-13Jallal Bahijan/aGrant563$0.00$05K
2026-05-13Neri Antonio Fn/aGrant563$0.00$05K
2026-05-13STRABLE-SOETHOUT DEANNA Dn/aGrant563$0.00$02K
2026-05-13SCHULMAN AMY Wn/aGrant563$0.00$0781
2026-05-13Schneider Ryan M.n/aGrant563$0.00$07K
2026-05-13PERU RAMIRO Gn/aGrant563$0.00$010K
2026-05-13HAY LEWIS IIIn/aGrant563$0.00$012K
2026-05-13Dixon Robert L JRn/aGrant563$0.00$011K
2026-05-13DeVore Susan D.n/aGrant563$0.00$04K
2026-05-13COLLIS STEVEN Hn/aGrant563$0.00$04K
2026-03-12SCHULMAN AMY Wn/aSell26$287.50$7K218
2026-03-06Kendrick Charles Morgan JREVP &amp; President, CommercialSell3K$284.92$911K12K
2026-03-05COLLIS STEVEN Hn/aBuy3K$289.84$870K4K
2026-03-03Wessling Erin MEVP &amp; Chief Legal OfficerTax withholding417$284.03$118K8K
2026-03-03Kendrick Charles Morgan JREVP &amp; President, CommercialTax withholding467$284.03$133K15K
2026-03-03Kaye MarkEVP &amp; CFOTax withholding353$284.03$100K32K
2026-03-03Norwood Felicia FEVP &amp;Chief Health Benefits OfrTax withholding496$284.03$141K39K
2026-03-03LAVU RATNAKAREVP &amp; Chief Digital Info OfrTax withholding222$284.03$63K16K
2026-03-03Penczek Ronald WCAO &amp; ControllerTax withholding37$284.03$11K4K
2026-03-03Haytaian Peter DEVP &amp; Pres Carelon &amp; CarelonRxTax withholding446$284.03$127K27K
2026-03-03Craig Ryan REVP &amp; Chief HR OfficerTax withholding309$284.03$88K7K
2026-03-03BOUDREAUX GAILPresident and CEOTax withholding2K$284.03$493K169K
2026-03-02Wessling Erin MEVP &amp; Chief Legal OfficerGrant3K$0.00$08K
2026-03-02Kendrick Charles Morgan JREVP &amp; President, CommercialGrant3K$0.00$015K
2026-03-02Kendrick Charles Morgan JREVP &amp; President, CommercialGrant4K$0.00$013K
2026-03-02Kendrick Charles Morgan JREVP &amp; President, CommercialTax withholding1K$294.07$356K9K
2026-03-02Kaye MarkEVP &amp; CFOGrant10K$0.00$032K
2026-03-02Kaye MarkEVP &amp; CFOGrant6K$0.00$022K
2026-03-02Kaye MarkEVP &amp; CFOTax withholding271$294.07$80K16K
2026-03-02Norwood Felicia FEVP &amp;Chief Health Benefits OfrGrant3K$0.00$039K
2026-03-02Norwood Felicia FEVP &amp;Chief Health Benefits OfrGrant6K$0.00$036K
2026-03-02Norwood Felicia FEVP &amp;Chief Health Benefits OfrTax withholding1K$294.07$418K31K
2026-03-02LAVU RATNAKAREVP &amp; Chief Digital Info OfrGrant7K$0.00$016K
2026-03-02LAVU RATNAKAREVP &amp; Chief Digital Info OfrGrant5K$0.00$010K
2026-03-02LAVU RATNAKAREVP &amp; Chief Digital Info OfrTax withholding315$294.07$93K4K
2026-03-02Penczek Ronald WCAO &amp; ControllerGrant266$0.00$04K
2026-03-02Penczek Ronald WCAO &amp; ControllerGrant2K$0.00$04K
2026-03-02Penczek Ronald WCAO &amp; ControllerGrant426$0.00$02K
2026-03-02Penczek Ronald WCAO &amp; ControllerTax withholding131$294.07$39K2K
2026-03-02Haytaian Peter DEVP &amp; Pres Carelon &amp; CarelonRxGrant3K$0.00$028K
2026-03-02Haytaian Peter DEVP &amp; Pres Carelon &amp; CarelonRxTax withholding1K$294.07$353K25K
2026-03-02Craig Ryan REVP &amp; Chief HR OfficerGrant3K$0.00$07K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

13F holders

Tracked managers holding ELV at their latest 13F. JSON

9 of the 30 tracked managers held ELV at their latest 13F, $1.71B in total at quarter-end prices. Citadel Advisors is the largest at $496.7M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 4 cut.

FundQuarterSharesValueOf portfolioChange in shares
Citadel Advisors2026-06-301.3M$496.7M0.06%-610K
Baupost Group2026-06-301.3M$493.1M9.11%0
Millennium Management2026-06-30837K$323.6M0.12%new or n/a
AQR Capital Management2026-06-30426K$164.4M0.06%+108K
Renaissance Technologies2026-06-30201K$77.9M0.11%+186K
Two Sigma Investments2026-06-30166K$64.3M0.05%+164K
D. E. Shaw & Co.2026-06-30152K$58.7M0.03%-262K
Point72 Asset Management2026-06-3067K$26.0M0.03%-18K
Fisher Asset Management2026-06-302K$623K0.00%-235

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q2 2026 (quarter ended 2026-06-30) Elevance Health, Inc. reported revenue of $50.47B, up 1.4% from the same quarter a year earlier, and net income of $1.46B (6.71 diluted EPS). In FY 2025 it generated $4.29B of operating cash flow and spent $2.60B on buybacks and $1.53B on dividends. As of 2026-06-30, cash was $10.23B against $31.04B of debt.

Cash
$10.23B
Debt
$31.04B
Equity
$44.88B
Total assets
$126.44B
Shares outstanding
216,869,290

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q2 20262026-06-30$50.47B$1.46B2.9%6.71
Q1 20262026-03-31$50.18B$1.76B3.5%8.00
Q4 2025derived2025-12-31$49.75B$547.0M1.1%n/a
Q3 20252025-09-30$50.71B$1.19B2.3%5.32
Q2 20252025-06-30$49.78B$1.74B3.5%7.72
Q1 20252025-03-31$48.89B$2.18B4.5%9.61
Q4 2024derived2024-12-31$45.44B$418.0M0.9%n/a
Q3 20242024-09-30$45.11B$1.02B2.3%4.36

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252025-12-31$199.13B$5.66B$4.29B$1.12B$2.60B$1.53B
FY 20242024-12-31$177.01B$5.98B$5.81B$1.26B$2.90B$1.51B
FY 20232023-12-31$171.34B$5.99B$8.06B$1.30B$2.68B$1.40B
FY 20222022-12-31$156.59B$5.89B$8.40B$1.15B$2.32B$1.23B
FY 20212021-12-31$138.64B$6.16B$8.36B$1.09B$1.90B$1.10B

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-10 from the cover page.

What this page is

Elevance Health, Inc. in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows Elevance Health, Inc. (ELV), SEC CIK 1156039, listed on NYSE, classified by the SEC as hospital & medical service plans. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest
FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-04.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials
SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
Insider trades
SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-03.JSON and CSV
Company record
EDGAR filing index for CIK 1156039Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as hospital & medical service plans

Datasets

Frequently Asked Questions

How much of ELV is sold short?
5,405,640 shares were held short at the 2026-08-14 settlement, 5.7 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ELV's daily short volume?
On 2026-09-11, 242,647 of the 371,533 ELV shares reported to FINRA were sold short, 65.3% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ELV have fails to deliver?
The SEC's latest file shows 1,635 ELV shares failed to deliver at settlement 2026-08-04. Fails are reported per settlement date and published twice a month with a lag.
Are ELV insiders buying or selling?
Insiders at ELV reported 2 open-market buys worth $1.0M in the last 90 days and no open-market sells. Clustered voluntary buying is historically the stronger insider signal because insiders buy for one reason. Latest filing: Wessling Erin M (EVP &amp; Chief Legal Officer) on 2026-09-03.
What did ELV report last quarter?
In Q2 2026 (quarter ended 2026-06-30) Elevance Health, Inc. reported revenue of $50.47B, up 1.4% from the same quarter a year earlier, and net income of $1.46B (6.71 diluted EPS). In FY 2025 it generated $4.29B of operating cash flow and spent $2.60B on buybacks and $1.53B on dividends. As of 2026-06-30, cash was $10.23B against $31.04B of debt.
Which funds hold ELV?
9 of the 30 tracked managers held ELV at their latest 13F, $1.71B in total at quarter-end prices. Citadel Advisors is the largest at $496.7M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 4 cut.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.